Hungary to be the first European country that can use bamlanivimab
The Covid-19 antibody drug bamlanivimab which Hungary has already authorised is effective against the new virus variant first discovered in the UK and the first shipment of the drug will arrive in Hungary on Wednesday, the human resources minister said.
Miklós Kásler said on Facebook that Hungary will be the first European country that can use bamlanivimab, developed by US drugmaker Eli Lilly.
He added that the National Institute of Pharmacy and Nutrition (OGYEI) approved the drug on December 12 for emergency, temporary use and the operative body responsible for the epidemic approved its acquisition. As a result, the Hungarian government was first to sign an agreement with the manufacturer in line with which a total of 6,236 ampoules are expected to arrive in three stages by the end of March.
The ministry said that 2,400 ampoules are expected to arrive on Wednesday, to be followed by 2,800 ampoules in the second half of February and 1,000 in the second half of March.
The statement cited Kásler saying that bamlanivimab can reduce the development of serious complications from coronavirus by 70-75 percent and the affected patients therefore need not be hospitalised.
Read alsoThe inoculate numbers are way too low for any restrictions to be eased, says chief medical officer
Source: MTI
please make a donation here
Hot news
Attention! Wizz Air to impose more fines for oversized baggage
German companies in Hungary worried about growing costs, decreasing consumption
Budapest Christmas markets open with moderate prices and discounts for tourists today
Hungary’s relations with Armenia developing after decade-long freeze
PM Orbán will build Europe’s most modern border crossing, sets finish date for 160 km/h railway line
Why choose Collaborator.pro for content marketing?
